{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:41Z","timestamp":1791356321677,"version":"4.3.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1023\/a:1025728524310","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T18:33:40Z","timestamp":1067020420000},"page":"129-136","source":"Crossref","is-referenced-by-count":31,"title":["Oral Contraceptives and the Risk of Ductal Breast Carcinoma in situ"],"prefix":"10.1007","volume":"81","author":[{"given":"Elizabeth B.","family":"Claus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5144334_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1056\/NEJM198608143150701","volume":"315","author":"The CancerSteroid Hormone Study of the Centers for Disease Controlthe National Institute of Child HealthHuman Development","year":"1986","unstructured":"The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development: Oral contraceptive use and the risk of breast cancer. N Engl J Med 315: 405\u2013411, 1986","journal-title":"N Engl J Med"},{"key":"5144334_CR2","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer.","year":"1996","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies: Lancet 347: 1713\u20131727, 1996","journal-title":"Lancet"},{"key":"5144334_CR3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","volume":"346","author":"PA Marchbanks","year":"2002","unstructured":"Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, et al.: Oral contraceptives and the risk of breast cancer. N Engl J Med 346: 2025\u20132032, 2002","journal-title":"N Engl J Med"},{"key":"5144334_CR4","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMe020051","volume":"346","author":"NE Davidson","year":"2002","unstructured":"Davidson NE, Helzlsouer KJ: Editorial. Good news about oral contraceptives. N Engl J Med 346: 2078\u20132079, 2002","journal-title":"N Engl J Med"},{"key":"5144334_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00694747","volume":"35","author":"R Millikan","year":"1995","unstructured":"Millikan R, Dressler L, Geradts J, Graham M: The need for epidemiologic studies of in situ carcinoma of the breast. Breast Cancer Res Treat 35: 65\u201377, 1995","journal-title":"Breast Cancer Res Treat"},{"key":"5144334_CR6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/bjc.1996.248","volume":"73","author":"HA Weiss","year":"1996","unstructured":"Weiss HA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB, Swanson CA: Epidemiology of in situ and invasive breast cancer in women aged under 45. Brit J Cancer 73: 1298\u20131305, 1996","journal-title":"Brit J Cancer"},{"key":"5144334_CR7","first-page":"961","volume":"5","author":"MP Longnecker","year":"1996","unstructured":"Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK: Risk factors for in situ breast cancer. Cancer Epidemiol, Biomarkers Prev 5: 961\u2013965, 1996","journal-title":"Cancer Epidemiol, Biomarkers Prev"},{"key":"5144334_CR8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.1983.03330280029024","volume":"249","author":"LA Brinton","year":"1983","unstructured":"Brinton LA, Hoover R, Fraumini Jr JF: Epidemiology of minimal breast cancer. JAMA 249: 483\u2013487, 1983","journal-title":"JAMA"},{"key":"5144334_CR9","first-page":"77","volume":"89","author":"K Kerlikowske","year":"1997","unstructured":"Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V: Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. JNCI 89: 77\u201382, 1997","journal-title":"JNCI"},{"key":"5144334_CR10","volume-title":"Risk factors for carcinoma in situ of the breast","author":"P Newcomb","year":"1994","unstructured":"Newcomb P, Storer BE, Marcus PM: Risk factors for carcinoma in situ of the breast. Abstract, American Society of Preventive Oncology, Bethesda, MD, 1994"},{"key":"5144334_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO;2-V","volume":"71","author":"EB Claus","year":"1993","unstructured":"Claus EB, Risch NR, Thompson WD, Carter D: Relationship between breast histopathology and family history of breast cancer. Cancer 71: 147\u2013153, 1993","journal-title":"Cancer"},{"key":"5144334_CR12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<330::AID-IJC3>3.0.CO;2-P","volume":"77","author":"M Lambe","year":"1998","unstructured":"Lambe M, Hsieh CC, Tsaih SW, Ekbom A, Trichopoulos D, Adami HO: Parity, age at first birth and the risk of carcinoma in situ of the breast. Intl J Cancer 77: 330\u2013332, 1998","journal-title":"Intl J Cancer"},{"key":"5144334_CR13","first-page":"193","volume":"1","author":"SL Saltzstein","year":"1996","unstructured":"Saltzstein SL: An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 case patients from the California Cancer Registry. Anat Pathol 1: 193\u2013203, 1996","journal-title":"Anat Pathol"},{"key":"5144334_CR14","first-page":"1273","volume":"73","author":"N Dubin","year":"1984","unstructured":"Dubin N, Hutter RVP, Strax P, Fazzini E, Schinella RA, Batang E, et al.: Epidemiology of minimal breast cancer among women screened in New York City. J Natl Cancer Inst 73: 1273\u20131279, 1984","journal-title":"J Natl Cancer Inst"},{"key":"5144334_CR15","unstructured":"Press MF, Bernstein L: Molecular epidemiology of breast carcinoma in situ. The US Army Medical Research and Material Command Annual Meeting, Atlanta 2000"},{"key":"5144334_CR16","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/93.23.1811","volume":"93","author":"EB Claus","year":"2001","unstructured":"Claus EB, Stowe M, Carter D: Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst 93: 1811\u20131817, 2001","journal-title":"J Natl Cancer Inst"},{"key":"5144334_CR17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jwh.1997.6.49","volume":"6","author":"GA Colditz","year":"1997","unstructured":"Colditz GA, Manson JE, Hankinson SE: The Nurses health study: 20-year contribution to the understanding of health among women. J Womens Health 6: 49\u201362, 1997","journal-title":"J Womens Health"},{"key":"5144334_CR18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/94.1.32","volume":"94","author":"JM Schildkraut","year":"2002","unstructured":"Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC: Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J Natl Cancer Inst 94: 32\u201338, 2002","journal-title":"J Natl Cancer Inst"},{"key":"5144334_CR19","unstructured":"Covington TR, Dipalma JR, Hussar DA, Lasagna L, Tatro DS, Whitsett TL (eds) Hormones. In: Drug Facts and Comparisons. J.B. Lippincott Co., St. Louis, MO, 1986"},{"key":"5144334_CR20","volume-title":"SAS\/STAT User's Guide","author":"SAS","year":"1989","unstructured":"SAS: SAS\/STAT User's Guide, Version 6, 4th edn, vol 1. SAS Institute Inc., Cary, NC, 1989","edition":"4th edn"},{"issue":"3","key":"5144334_CR21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3322\/canjclin.47.3.150","volume":"47","author":"ACS Guidelines for the early detection of breast cancer: Update 1997.","year":"1997","unstructured":"ACS Guidelines for the early detection of breast cancer: Update 1997. CA Cancer J Clin 47(3): 150\u2013153, 1997","journal-title":"CA Cancer J Clin"},{"key":"5144334_CR22","unstructured":"NIH Consensus Statement Online 1997 Jan 21-23; 15(1): 1-35. http:\/\/odp.od.nih.gov\/consensus\/cons\/103\/103_ statement.htm"},{"key":"5144334_CR23","unstructured":"Breast Cancer Screening for Women Ages 40-49: NIH Consensus Statement Online 1997 Jan 21-23; 15(1): 1-35. http:\/\/odp.od.nih.gov\/consensus\/cons\/103\/103_statement.htm"},{"key":"5144334_CR24","first-page":"3678","volume":"57","author":"G Ursin","year":"1997","unstructured":"Ursin G, Henderson BE, Haile RW, Pike MC, Zhou N, Diep A, Bernstein L: Does oral contraceptive use increase the risk of breast cancer in women with BRCA1\/BRCA2 mutations more than in other women? Cancer Res 57: 3678\u20133681, 1997","journal-title":"Cancer Res"},{"key":"5144334_CR25","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/jama.284.14.1791","volume":"284","author":"DW Grabick","year":"2000","unstructured":"Grabick DW, Hartman LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM, et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 284: 1791\u20131798, 2000","journal-title":"JAMA"},{"key":"5144334_CR26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00001648-200009000-00026","volume":"11","author":"G Ursin","year":"2000","unstructured":"Ursin G, Li C, Pike M: Should women with a family history of breast cancer avoid use of oral contraceptives? Epidemiol 11: 615, 2000","journal-title":"Epidemiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025728524310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1025728524310\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1025728524310","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025728524310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:34:45Z","timestamp":1750894485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1025728524310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["5144334"],"URL":"https:\/\/doi.org\/10.1023\/a:1025728524310","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}